| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |